Neuren Pharmaceuticals Limited (AU:NEU) has released an update.
Neuren Pharmaceuticals Limited has announced the cessation of 150,000 stock options due to the unmet or unfulfillable conditions, as detailed in their latest securities update on May 7, 2024. The options, which were set to expire on February 7, 2029, at $23.09, have lapsed, reflecting changes in the company’s capital structure.
For further insights into AU:NEU stock, check out TipRanks’ Stock Analysis page.
